ArticleInvestigational new drugs2020

Phase 1 dose escalation trial of TAS-102 (trifluridine/tipiracil) and temozolomide in the treatment of advanced neuroendocrine tumors.

Nataliya V Uboha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.